<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635897">
  <TermName>R-CHOP regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An abbreviation
          for a chemotherapy combination that is used to treat
          non-Hodgkin lymphoma and mantle cell lymphoma and is being
          studied in the treatment of other types of cancer. It
          includes the drugs rituximab, cyclophosphamide, doxorubicin
          hydrochloride (hydroxydaunorubicin), vincristine sulfate
          (Oncovin), and prednisone. Also called R-CHOP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000723243" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;R-CHOP regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000723244" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen R-CHOP&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen R-CHOP</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre 
de una quimioterapia combinada que se usa para el
tratamiento del linfoma no Hodgkin y el linfoma de células del manto. También está
en estudio para el tratamiento de otros tipos de cáncer.
Incluye los medicamentos rituximab, ciclofosfamida,
clorhidrato de doxorrubicina (hidroxidaunorrubicina),
sulfato de vincristina (Oncovin) y prednisona. También se llama R-CHOP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-23</DateFirstPublished>
  <DateLastModified>2010-05-05</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000636199" url="/about-cancer/treatment/drugs/R-CHOP">R-CHOP</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
